Unfashionably late

New England Journal of Medicine

Volumn 352, Issue 1, 2005, Pages 64-69

  Lukela, Michael ^a,b,e   DeGuzman, David ^a   Weinberger, Steven ^c   Saint, Sanjay ^d  

^a Department of Internal Medicine ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFEPIME; CEFTRIAXONE; CLINDAMYCIN; PREDNISONE; CHLORIDE; GLUCOCORTICOID;

ADULT; ANAMNESIS; ARTICLE; BREATHING DISORDER; BRONCHIOLITIS OBLITERANS; BRONCHUS BIOPSY; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DYSPNEA; FAMILY HISTORY; GENETIC SCREENING; HUMAN; LABORATORY TEST; LUNG FUNCTION TEST; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NEUTROPHIL; ORGANIZING PNEUMONIA; PLEURISY; PRIORITY JOURNAL; SEROLOGY; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VIRUS DETECTION; ADOLESCENT; BACTERIAL INFECTION; BIOPSY; BURKHOLDERIA CEPACIA; CHEMISTRY; COUGHING; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; ISOLATION AND PURIFICATION; LUNG; METABOLISM; PATHOLOGY; PLEURA DISEASE; RADIOGRAPHY; RESPIRATORY BURST; SWEAT;

ADOLESCENT; BIOPSY; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHEST PAIN; CHLORIDES; COUGH; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; GLUCOCORTICOIDS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LUNG; MALE; PLEURAL DISEASES; PREDNISONE; RESPIRATORY BURST; SWEAT;

EID: 11344280902     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcps041234     Document Type: Article

References (14)

1. Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med 1957;40:309-12.
2. Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood: the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child 1959;97:387-408.
3. Baehner RL, Nathan DG. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science 1967;155:835-6.
4. Quie PG, White JG, Holmes PG, Good RA. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967;46:668-79.
5. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155-69.
6. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000;79:170-200.
7. Johnston RB Jr. Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 2001;8:17-22.
8. Barton LL, Moussa SL, Villar RG, Hulett RL. Gastrointestinal complications of chronic granulomatous disease: case report and literature review. Clin Pediatr (Phila) 1998;37:231-6.
9. Baehner RL, Boxer LA, Davis J. The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood 1976;48:309-13.
10. Jirapongsananuruk O, Malech HL, Kuhns DB, et al. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol 2003;111:374-9.
11. Cale CM, Jones AM, Goldblatt D. Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol 2000;120:351-5.
12. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989;114:555-60.
13. Gallin JI, Malech HL, Weening RS, et al. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-16.
14. Malech HL. Progress in gene therapy for chronic granulomatous disease. J Infect Dis 1999;179:Suppl 2:S318-S325.